Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-kappaB inhibition


Aim: : Hydrogen sulfide (H2S), together with nitric oxide (NO) and carbon monoxide (CO), belongs to a family of endogenous signaling mediators termed “gasotransmitters”. Recent studies suggest that H2S modulates many cellular processes and it has been recognized to play a central role in inflammation, in the cardiovascular and nervous systems.

By infecting monocytes/macrophages with Mycoplasma fermentans (M.F.), a well-known pro-inflammatory agent, we evaluated the effects of H2S.

Methods:
M.F.-infected cells were analyzed by ELISA and real time RT-PCR to detect the M.F. effects on MCP-1 and on MMP-12 expression.

The role of two different H2S donors (NaHS and GYY4137) on MF-infected cells was determined by treating infected cells with H2S and then testing the culture supernatants for MCP-1 and on MMP-12 production by ELISA assay. In order to identify the pathway/s mediating H2S- anti-inflammatory activity, cells were also treated with specific pharmaceutical inhibitors.

Cytoplasmic and nuclear accumulation of NF-kappaB heterodimers was analyzed.

Results:
We show that H2S was able to reduce the production of pro-inflammatory cytokine MCP-1, that was induced in monocytes/macrophages during M.F. infection.

Moreover, MCP-1 was induced by M.F. through Toll-like receptor (TLR)-mediated nuclear factor-kappaB (NF-kappaB) activation, as demonstrated by the fact that TLR inhibitors TIRAP and MyD88 and NF-kappaB inhibitor IKK were able to block the cytokine production.

In contrast H2S treatment of M.F. infected macrophages reduced nuclear accumulation of NF-kappaB heterodimer p65/p52.

Conclusions:
Our data demonstrate that under the present conditions H2S is effective in reducing Mycoplasma-induced inflammation by targeting the NF-kappaB pathway.

This supports further studies for possible clinical applications.

Author: Francesca BenedettiSergio DavinelliSelvi KrishnanRobert C GalloGiovanni ScapagniniDavide ZellaSabrina Curreli
Credits/Source: Journal of Translational Medicine 2014, 12:145

Published on: 2014-05-24

Tweet

News Provider: 7thSpace Interactive

Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo

There are no comments available. Be the first to write a comment.